Godavari Biorefineries Q4 FY26 Earnings Call Transcript Released
Godavari Biorefineries reported FY26 total income of ₹2,000 crores, up 6% YoY, with EBITDA at ₹139 crores. Q4 FY26 revenue was ₹564 crores and EBITDA ₹92 crores. A 200 KLPD grain-based distillery is expected by June 2026. The company achieved positive PAT of ₹3.5 crores in FY26 after a loss in FY25.
The announcement relates to a conference call transcript, providing details on past performance and future outlook. While positive, it does not contain immediate, significant corporate actions or financial results that would cause a high impact.
The company reported a turnaround in profitability, increased revenue and EBITDA, and achieved its highest ever cane crushing. Positive outlook for bio-based chemicals and upcoming distillery expansion contribute to a positive sentiment.
Godavari Biorefineries Limited has released the transcript of its Investor/Analyst Conference Call held on May 26, 2026, to discuss the financial performance for Q4 and the full fiscal year 2026. The call featured insights from Mr. Samir Somaiya, Chairman and Managing Director, and Mr. Ashish Sinha, Assistant General Manager, Investor Relations and Finance.
During the call, Mr. Somaiya highlighted the company's resilience and turnaround in profitability for FY26, with total income at ₹2,000 crores (up 6% YoY) and EBITDA at ₹139 crores (up 15.8% YoY), achieving a positive profit after tax of ₹3.5 crores. Q4 FY26 saw a strong sequential recovery with revenue from operations at ₹564 crores and EBITDA at ₹92 crores, with margins stabilizing at 16.2%. The company achieved its highest ever cane crushing of 2.5 million tons in the 2025-2026 season. The bio-based chemical segment revenue stood at ₹578 crores for FY26, with efforts focused on increasing specialty production and debottlenecking operations. The ethanol business reported revenue of ₹658 crores, selling approximately 98 million liters. The consumer business, Jivana, showed strong traction with ₹129 crores in revenue for FY26.
Looking ahead, the company's strategic priorities include expanding specialty chemicals, strengthening the ethanol platform, and scaling the consumer business. The commissioning of a 200 KLPD grain-based distillery, expected by June 2026, is set to add approximately 60 million liters of annual ethanol capacity. The company also discussed its advancements in developing an oral therapy candidate for triple-negative breast cancer and strengthening its antiviral platform. The ongoing geopolitical developments and rising fuel costs are seen as accelerating the shift towards sustainable and bio-based alternatives, strengthening Godavari Biorefineries' position.
Mr. Sinha detailed the financial performance, noting a significant improvement in the capital structure with finance costs reduced by 32% to ₹49 crores due to a debt repayment of ₹240 crores in FY25. Profit after tax for Q4 FY26 stood at ₹52.9 crores. The integrated sugar, ethanol, and co-generation business reported revenues of approximately ₹1,383 crores and EBITDA at ₹97.4 crores for the full year, while the bio-based chemical segment saw an increase in the percentage of specialty chemicals to 61%. The company is exploring opportunities in bio-butanol, DME, and next-generation renewable technologies.
What to do with a filing like this
Godavari Biorefineries Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Godavari Biorefineries Limited. Read the original for the full detail.